In malignant cartilagenous tumors, immunohistochemical expression of procollagen PC1CP peptide is higher and that of PC2CP lower than in benign cartilaginous lesions.
Few studies on oncogenesis of chondrosarcoma (CS) are available in the literature. Our previously published experimental evidence suggests that while the C-propeptide of procollagen Iα1 (PC1CP), a component of cartilage, favors tumor progression, the C-propeptide of procollagen IIα1 (PC2CP) exerts a...
| Published in: | Virchows Archiv: European Journal of Pathology Vol. 467; no. 3; pp. 329 - 338 |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Journal Article |
| Published: |
Springer Nature
Sep2015
|
| Online Access: | View this record in EBSCOhost |